Cardiac risk factors and myocardial perfusion reserve in women with microvascular coronary dysfunction (scientific article published on September 2013)

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Q27860959

Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

Q33198363

Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study.

Q33967744

Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study

Q34313090

Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms

Q34507733

Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study

Q35754796

Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies.

Q36386704

Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute spons

Q36536790

Contraceptive hormone use and cardiovascular disease

Q37138852

Cardiac magnetic resonance imaging myocardial perfusion reserve index assessment in women with microvascular coronary dysfunction and reference controls

Q37339422

Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project

Q37436667

The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report

Q41666188

Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study

Q43924278

Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging

Q44035382

Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

Q44936581

Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus

Q45844952

Coronary risk factors and myocardial perfusion in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA).

Q46927563

Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function.

Q54037552

Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy.

Q54373170

Angina with “normal” coronary arteries: Sex differences in outcomes

Q58666290

Hypertension, Menopause, and Coronary Artery Disease Risk in the Women’s Ischemia Syndrome Evaluation (WISE) Study

Q61070488

Comparison of 15-year survival for men and women after initial medical or surgical treatment for coronary artery disease: a CASS registry study. Coronary Artery Surgery Study

Q72646273

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

Q73912535

Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study

Q77766223

Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE)

Q79839663

P433

issue

P921

main subject

microvessel

Q6840468

P304

page(s)

146-152

P577

publication date

2013-09-01

P1433

published in

Cardiovascular diagnosis and therapy

Q26842243

P1476

title

Cardiac risk factors and myocardial perfusion reserve in women with microvascular coronary dysfunction

P478

volume

Reverse relations

cites work (P2860)

Q26776330	A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve
Q35077560	Current Diagnostic and Therapeutic Strategies in Microvascular Angina
Q47171821	Daily Activity Measured With Wearable Technology as a Novel Measurement of Treatment Effect in Patients With Coronary Microvascular Dysfunction: Substudy of a Randomized Controlled Crossover Trial.
Q36202061	Emergence of Nonobstructive Coronary Artery Disease: A Woman's Problem and Need for Change in Definition on Angiography
Q91725769	The current state of biomarker research for Friedreich's ataxia: a report from the 2018 FARA biomarker meeting
Q39560578	The role of stress cardiac magnetic resonance in women